FIELD: organic chemistry, medicine, hematology.
SUBSTANCE: invention relates to synthesis of biologically active derivatives of pyridylisoquinolines. Invention describes 2,2-dimethyl-4-(4,6-dimethyl-2-pyridon-3-yl)-1,2-dihydrobenzo[f]isoquinoline hydrochloride of the formula: 
that elicits the direct anticoagulant effect. Invention provides preparing a novel compound possessing useful biological properties.
EFFECT: valuable biological property of compound.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 1-(3,4-DIETHOXYPHENYL)-2,3,5,6-TETRAHYDRO-(3,4-DIETHOXYBENZO) [g]QUINOXALINO[2,3-b]INDOLIZINE HYDROCHLORIDE OF DIRECT ANTICOAGULATION EFFECT | 2006 |
|
RU2330850C1 |
| 1,4,5,6-TETRAHYDRO-6-OXO-5-(2-PIPERAZINOETHYL)-4-PHENYL-3-(4-CHLOROPHENYL)PYRROLO[3.4-C]PYRAZOLE DIHYDROCHLORIDE ELICITING HYPOTENSIVE AND ANTI-COAGULANT ACTIVITY | 2006 |
|
RU2320661C2 |
| 4,6-DIMETHYL-1H-2-OXONICOTINIC ACID 3-HYDROXYPROPYLAMIDE ELICITING ANTICOAGULANT, ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY | 2006 |
|
RU2315040C1 |
| N-ISOPROPYLAMIDE 2-(6,7-DIMETHOXY-3-SPIRO-CYCLOPENTYL-3,4-DIHYDROISOQUINOLYL-1)-ETHANOIC ACID HYDROCHLORIDE, WHICH POSSESSES HYPERTENSIVE ACTIVITY | 2010 |
|
RU2491277C2 |
| 2-(4'CHLOROPHENOXY)-N,N-DIETHYLETHANAMINE HYDROCHLORIDE MEDIUM WITH DIRECT ANTICOAGULATION EFFECT | 2007 |
|
RU2348610C2 |
| THIAZOLINE AMMONIUM 2-HYDROXY-4-OXO-4-(4-CHLOROPHENYL)-2-BUTENOATE, HAVING ANTICOAGULATION ACTIVITY | 2009 |
|
RU2461550C2 |
| 2-HYDROXY-4-OXO-4-(4'-CHLOROPHENYL)-BUT-2-ENOAT 4-METHYL-2-PYRIDYLAMMONIUM THAT HAS A DIRECT ANTICOAGULANT ACTION | 2015 |
|
RU2649140C2 |
| 4-ACETYL-3-HYDROXY-1-(2-HYDROXYETHYLAMINOETHYL)-5-PHENYL-3-PYRROLIN-2-ONE ELICITING ANTI-COAGULANT ACTIVITY | 2005 |
|
RU2312660C2 |
| MALEIC ACID 3-METHYL-2-PYRIDYLAMIDE ELICITING DIRECT ANTICOAGULANT EFFECT | 2005 |
|
RU2294199C2 |
| 2-HYDROXY-4-OXO-4-(4-CHLOROPHENYL)-2-BUTENOATE 2-[(6-ETHOXY)BENZO[D]-THIAZOLYL]AMMONIUM WITH ANTHELMINTIC AND INSECTICIDAL ACTIVITY | 2016 |
|
RU2657246C2 |
